We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+43.8%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
AUM
$355M
AUM Growth
+$33.5M
Cap. Flow
-$37.1M
Cap. Flow %
-10.46%
Top 10 Hldgs %
73.07%
Holding
49
New
10
Increased
6
Reduced
11
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 39.35%
2 Technology 14.51%
3 Industrials 6.28%
4 Communication Services 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
1
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$110M 31.15%
500,000
-500,000
-50% -$49.1M
GLW icon
2
CALL
Corning
GLW
$107B
$30.5M 8.6%
+675,000
New +$28.4M
PSNL icon
3
Personalis
PSNL
$1.25B
$21.5M 6.07%
+3,999,064
New +$16.5M
SCPH
4
DELISTED
scPharmaceuticals
SCPH
$18.8M 5.3%
4,124,367
+620,002
+18% +$3M
ARQ icon
5
Arq
ARQ
$83.7M
$16.5M 4.66%
2,817,078
+675,000
+32% +$4.11M
DCTH icon
6
Delcath Systems
DCTH
$399M
$16.1M 4.54%
1,782,490
-617,302
-26% -$5.36M
APPS icon
7
Digital Turbine
APPS
$982M
$13.8M 3.89%
+4,490,140
New +$12.1M
MYO icon
8
Myomo
MYO
$35.9M
$11.1M 3.14%
2,778,848
-139,149
-5% -$576K
GLW icon
9
Corning
GLW
$107B
$10.2M 2.87%
+225,000
New +$9.47M
BDSX icon
10
Biodesix
BDSX
$212M
$10.1M 2.85%
283,991
-5,000
-2% -$172K
ELUT icon
11
Elutia
ELUT
$39.3M
$9.56M 2.7%
2,510,442
+813,126
+48% +$3.17M
CLRB icon
12
Cellectar Biosciences
CLRB
$19.7M
$6.84M 1.93%
106,580
+5,374
+5% +$354K
TARS icon
13
Tarsus Pharmaceuticals
TARS
$2.56B
$6.72M 1.9%
+204,413
New +$5.75M
TELA icon
14
TELA Bio
TELA
$30.3M
$6.25M 1.76%
2,469,373
+812,718
+49% +$2.89M
XERS icon
15
Xeris Biopharma Holdings
XERS
$1.45B
$6.23M 1.76%
+2,185,654
New +$5.61M
BKTI icon
16
BK Technologies
BKTI
$294M
$6.16M 1.74%
282,772
IPWR icon
17
Ideal Power
IPWR
$55M
$5.74M 1.62%
700,000
ELVA
18
Electrovaya
ELVA
$380M
$5.72M 1.61%
2,447,626
-127,802
-5% -$288K
LPTH icon
19
Lightpath Technologies
LPTH
$593M
$5.1M 1.44%
3,723,932
THTX
20
DELISTED
Theratechnologies
THTX
$4.61M 1.3%
3,725,204
EGRX
21
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4.52M 1.27%
1,211,509
COYA icon
22
Coya Therapeutics
COYA
$90.8M
$4.19M 1.18%
649,427
IDN icon
23
Intellicheck
IDN
$75.1M
$3.84M 1.08%
1,767,732
PYPD icon
24
PolyPid
PYPD
$78M
$2.37M 0.67%
679,668
+200,422
+42% +$720K
MRAM icon
25
Everspin Technologies
MRAM
$302M
$2.21M 0.62%
+373,888
New +$2.17M

Similar funds

AIGH Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, AIGH Capital Management held 49 positions worth $355M, up 10% from $321M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

AIGH Capital Management withdrew a net $37.1M in Q3 2024, closing 9 positions and reducing 11 holdings. Its most notable exit was Silicon Motion, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Personalis worth $21.5M.

  • AIGH Capital Management's largest Q3 2024 buy was Personalis: 3,999,064 shares worth $21.5M.
  • AIGH Capital Management added most to Arq in Q3 2024, an estimated $4.11M increase.
  • AIGH Capital Management's biggest Q3 2024 reduction was Delcath Systems, cutting an estimated $5.36M.
  • AIGH Capital Management fully exited Silicon Motion in Q3 2024, selling an estimated $22.3M.
  • AIGH Capital Management's ten largest holdings make up 73% of its $355M portfolio in Q3 2024.
  • AIGH Capital Management opened 10 new positions and closed 9 in Q3 2024.
  • AIGH Capital Management's portfolio value rose 10% quarter-over-quarter to $355M.

Based on AIGH Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.